一种由阿迪波内克丁衍生的短的骨质效应,可以重新平衡骨重塑:一种潜在的疾病修饰方法,用于绝经后骨质疏松症治疗
Swati Rajput1,2, Chirag Kulkarni1,2, Shivani Sharma1,2
1Division of Endocrinology and Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI), CSIR-Central Drug Research Institute, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow, 226031, India.
Archives of pharmacal research
|July 29, 2024
概括
一种新型的,ADP-1,来自皮质,有效地促进骨的形成,并减少骨的再吸收. 这种双重作用分子通过改善骨质量和强度来治疗骨质疏松症.
科学领域:
- 内分泌学和新陈代谢学
- 骨生物学和骨质疏松症研究研究
- 分子和细胞生物学分子和细胞生物学
背景情况:
- 阿迪波内克调节新陈代谢过程,影响骨新陈代谢.
- 全球性氨酸 (gAd) 显示出骨质代谢和抗代谢作用.
- 一个片段,ADP-1,模仿阿迪波内克的特性.
研究的目的:
- 为了研究由阿迪波内克丁衍生的甲酸ADP-1的骨质生成潜力.
- 阐明ADP-1对骨的影响背后的机制.
- 为了评估ADP-1在骨质疏松症的动物模型中的疗效.
主要方法:
- 在体外评估骨质母细胞的分化和功能.
- 研究了下游的信号通路,包括线粒体生物发生和Akt/GSK3β/Wnt通路.
- 测量了核因子卡帕-B连接体 (RANKL) 生产的受体激活剂.
- 给卵巢切除的老鼠服用ADP-1,以评估骨质,强度和微观架构的体内影响.
主要成果:
- 通过AdipoR1/R2.2,ADP-1强烈诱导骨质母细胞的分化.
- 观察到增强的线粒体生物发生和氧化酸化 (OxPhos).
- 激活了Akt-糖原合成酶激酶3β-Wnt信号通路.
- 抑制了RANKL的产生,表明对骨重塑的双重作用.
- 增加骨质量,强度和骨完整性在骨性大鼠中.
- 在体内刺激骨形成和抑制骨再吸收.
结论:
- 通过涉及AdipoR1/R2.2的双重机制,ADP-1表现出强大的骨质生成性.
- 它通过促进线粒体活动和激活Wnt信号来增强骨质细胞功能.
- 由于ADP-1能够抑制骨质细胞形成,因此它是骨质疏松症的有希望的治疗候选者.
- 这种可以为骨质疏松症中异常骨重塑提供潜在的疾病修饰治疗.
相关概念视频
Bone Remodeling
38.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.2K
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Hormones and Bone Tissue
2.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.6K


